tp53 mutation

Showing 1 - 2 of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Endometrioid Tumor, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Ovarian Endometrioid Tumor
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 21, 2021

DLBCL, Sintilimab, TP53 Mutation Trial (Sintilimab-R-CHOP)

Unknown status
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • (no location specified)
Dec 9, 2019